Edition:
United Kingdom

Miragen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

7.97USD
5:46pm GMT
Change (% chg)

$-0.03 (-0.38%)
Prev Close
$8.00
Open
$8.01
Day's High
$8.25
Day's Low
$7.96
Volume
8,219
Avg. Vol
24,909
52-wk High
$17.83
52-wk Low
$4.65

Select another date:

Wed, Nov 8 2017

BRIEF-Miragen Therapeutics reports third quarter financial results

* Miragen Therapeutics reports third quarter 2017 financial results and provides corporate update

BRIEF-Miragen Therapeutics presents new data suggesting positive impact from systemically administered MRG-106

* Miragen Therapeutics presents new clinical data suggesting positive impact from systemically administered MRG-106 on mycosis fungoides form of cutaneous T-cell lymphoma at EORTC global task force meeting

BRIEF-Miragen Therapeutics presents new MRG-201 preclinical data

* Miragen Therapeutics presents new MRG-201 preclinical data for Inhaled Microrna-29 Mimic Targeting Pulmonary Fibrosis Source text for Eikon: Further company coverage:

BRIEF-Miragen Therapeutics Q2 loss per share $0.34

* Miragen Therapeutics reports second quarter 2017 financial results and provides corporate update

Select another date: